New finance directors at Goodrich, Netflix top the week's comings and goings, but what's up at KV Pharmaceutical?
This week's churn sees big glassmaker put its CFO on ice, and new faces at several pharma and tech companies.
Collective trust funds are more than lower cost mutual fund clones, at least for now.
Second plant in two days shuts down over worker demands.
The week saw several new tech industry CFOs, including one who's part of a big management shake-up.
Is your company saving cash? ARS still a pain in the backside for CFOs Health-care reform verdict? People are cattle
in Deal Talk by 
